{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:27:49Z","timestamp":1763036869833},"reference-count":16,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1111\/jcpt.12221","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T11:10:53Z","timestamp":1412939453000},"page":"116-118","source":"Crossref","is-referenced-by-count":2,"title":["Carcinoma of the salivary glands: guidelines and case report of sustained remission with docetaxel"],"prefix":"10.1155","volume":"40","author":[{"given":"J.","family":"Arrondeau","sequence":"first","affiliation":[{"name":"Service d'Oncologie Radioth\u00e9rapie; H\u00f4pital Tenon; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Le Nagat","sequence":"additional","affiliation":[{"name":"Service d'Oncologie Radioth\u00e9rapie; H\u00f4pital Tenon; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lef\u00e8vre","sequence":"additional","affiliation":[{"name":"Service d'Anatomie Pathologique; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tassart","sequence":"additional","affiliation":[{"name":"Service de Radiodiagnostic; H\u00f4pital Tenon; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Touboul","sequence":"additional","affiliation":[{"name":"Service d'Oncologie Radioth\u00e9rapie; H\u00f4pital Tenon; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lacau St Guily","sequence":"additional","affiliation":[{"name":"Service d'ORL et de Chirurgie Cervicofaciale; H\u00f4pital Tenon; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[{"name":"Service d'Oncologie Radioth\u00e9rapie; H\u00f4pital Tenon; Assistance Publique des H\u00f4pitaux de Paris; GHU Est; Universit\u00e9 Paris VI; Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"key":"10.1111\/jcpt.12221-BIB0001|jcpt12221-cit-0001","first-page":"47","article-title":"Incidence, diagnosis, and classification of salivary gland tumors. Part 1","volume":"3","author":"Johns","year":"1989","journal-title":"Oncology (Williston Park, NY)"},{"key":"10.1111\/jcpt.12221-BIB0002|jcpt12221-cit-0002","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/003655402_000028047","article-title":"Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes","volume":"122","author":"Brandwein","year":"2002","journal-title":"Acta Otolaryngol"},{"key":"10.1111\/jcpt.12221-BIB0003|jcpt12221-cit-0003","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C","article-title":"Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria","volume":"82","author":"Goode","year":"1998","journal-title":"Cancer"},{"key":"10.1111\/jcpt.12221-BIB0004|jcpt12221-cit-0004","first-page":"735","article-title":"2008 Update of Standards, Options: recommendations for management of patients with salivary gland malignant tumours (excluding lymphoma, sarcoma and melanoma), summary report","volume":"95","author":"Bensadoun","year":"2008","journal-title":"Bull Cancer"},{"key":"10.1111\/jcpt.12221-BIB0005|jcpt12221-cit-0005","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"24","author":"Laurie","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/jcpt.12221-BIB0006|jcpt12221-cit-0006","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12221-BIB0007|jcpt12221-cit-0007","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12221-BIB0008|jcpt12221-cit-0008","first-page":"4721","article-title":"Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer","volume":"20","author":"Shin","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1111\/jcpt.12221-BIB0009|jcpt12221-cit-0009","first-page":"4713","article-title":"Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study","volume":"25","author":"Petris","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1111\/jcpt.12221-BIB0010|jcpt12221-cit-0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00280-008-0870-z","article-title":"Biweekly docetaxel in recurrent ovarian cancer: a phase I dose finding study","volume":"64","author":"Maenpaa","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/jcpt.12221-BIB0011|jcpt12221-cit-0011","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jjco\/hyr050","article-title":"A phase I study of bi-weekly docetaxel for recurrent or advanced gastric cancer patients whose disease progressed by prior chemotherapy","volume":"41","author":"Kimura","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1111\/jcpt.12221-BIB0012|jcpt12221-cit-0012","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MLG.0b013e31815a6b0b","article-title":"Management and outcome of patients with mucoepidermoid carcinoma of major salivary gland origin: a single institution's 30-year experience","volume":"118","author":"Aro","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1111\/jcpt.12221-BIB0013|jcpt12221-cit-0013","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/14737140.8.3.393","article-title":"Systemic therapies for recurrent and\/or metastatic salivary gland cancers","volume":"8","author":"Vattemi","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1111\/jcpt.12221-BIB0014|jcpt12221-cit-0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hed.20327","article-title":"Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group","volume":"28","author":"Gilbert","year":"2006","journal-title":"Head Neck"},{"key":"10.1111\/jcpt.12221-BIB0015|jcpt12221-cit-0015","first-page":"870","article-title":"Anticancer activity of docetaxel in murine salivary gland carcinoma","volume":"8","author":"Piechocki","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/jcpt.12221-BIB0016|jcpt12221-cit-0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1741-9409(03)00003-7","article-title":"Docetaxel (Taxotere) in recurrent high grade mucoepidermoid carcinoma of the major salivary glands","volume":"40","author":"Raguse","year":"2004","journal-title":"Oral Oncol Extra"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12221","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12221","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12221\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:05:37Z","timestamp":1671818737000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12221","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,10]]}}}